CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion

K Koike1, E E Moore, F A Moore

  • 1Department of Surgery, Denver General Hospital and the University of Colorado Health Sciences Center, Denver Colorado.

Insights

Gut ischemia/reperfusion causes lung injury. Blocking CD11b/CD18 prevents lung leak but not neutrophil priming or accumulation, indicating its critical role in endothelial injury.

Area of Science:

  • Gastroenterology
  • Pulmonology
  • Immunology

Background:

  • Gut ischemia/reperfusion (I/R) is a significant cause of distant organ injury, particularly lung injury.
  • Neutrophils, specifically polymorphonuclear neutrophils (PMNs), play a crucial role in mediating I/R-induced lung injury.
  • The CD11b/CD18 integrin is vital for PMN adhesion and activation, influencing oxidative burst.

Purpose of the Study:

  • To elucidate the specific role of the CD11b integrin in the pathogenesis of gut I/R-induced lung injury.
  • To investigate whether CD11b blockade can mitigate lung injury following gut I/R.
  • To determine the impact of CD11b blockade on PMN priming and tissue infiltration.

Main Methods:

  • Sprague-Dawley rats underwent superior mesenteric artery (SMA) occlusion for 45 minutes, with or without CD11b monoclonal antibody (IB6) treatment.
  • Myeloperoxidase activity was measured to quantify PMN accumulation in tissues.
  • Circulating PMN priming and lung vascular permeability (lung leak) were assessed post-reperfusion.

Main Results:

  • CD11b blockade significantly prevented lung leak induced by gut I/R.
  • However, CD11b blockade did not attenuate the priming of circulating PMNs.
  • Tissue PMN accumulation was also not reduced by CD11b blockade, suggesting alternative adhesion mechanisms.

Conclusions:

  • Gut I/R induces PMN priming and adhesion through pathways independent of CD11b.
  • The CD11b/CD18 integrin is essential for PMN-mediated endothelial injury, rather than PMN recruitment or activation in this model.
  • Targeting CD11b may be a therapeutic strategy to prevent endothelial damage in I/R injury.

Related Concept Videos